These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 8179841)

  • 1. Probing modifications of the neuronal cytoskeleton.
    Doering LC
    Mol Neurobiol; 1993; 7(3-4):265-91. PubMed ID: 8179841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function.
    Sánchez C; Díaz-Nido J; Avila J
    Prog Neurobiol; 2000 Jun; 61(2):133-68. PubMed ID: 10704996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.
    Henriques AG; Oliveira JM; Carvalho LP; da Cruz E Silva OAB
    Mol Neurobiol; 2015 Dec; 52(3):1391-1407. PubMed ID: 25344315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 1994 Dec; 747():92-109. PubMed ID: 7847694
    [No Abstract]   [Full Text] [Related]  

  • 6. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
    Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
    Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.
    Benitez-King G; Ramírez-Rodríguez G; Ortíz L; Meza I
    Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):515-33. PubMed ID: 15581421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton.
    Refolo LM; Wittenberg IS; Friedrich VL; Robakis NK
    J Neurosci; 1991 Dec; 11(12):3888-97. PubMed ID: 1683901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of fetal CNS tissue into the peripheral nervous system: a model to study aberrant changes in the neuronal cytoskeleton.
    Doering LC
    J Neural Transplant Plast; 1991; 2(3-4):193-205. PubMed ID: 1664243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of the cytoskeleton].
    Dustin P; Brion JP
    Ann Pathol; 1988; 8(1):3-19. PubMed ID: 3293578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in neurofilaments and the transformation of the cytoskeleton in axons may provide insight into the aberrant neuronal changes of Alzheimer's disease.
    Vickers JC; Kirkcaldie MT; Phipps A; King AE
    Brain Res Bull; 2016 Sep; 126(Pt 3):324-333. PubMed ID: 27475416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.
    Grace EA; Busciglio J
    J Neurosci; 2003 Jan; 23(2):493-502. PubMed ID: 12533609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
    Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
    J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.